Alternative medicine funding expansion to FDA, CDC suggested at NIH hearing.
This article was originally published in The Tan Sheet
Executive Summary
FEDERAL ALTERNATIVE MEDICINE RESEARCH FUNDING EXPANSION TO FDA, the Centers for Disease Control & Prevention and other HHS agencies was suggested by David Eisenberg, MD, Beth Israel/Deaconess Medical Center, Boston, at an Oct. 8 Senate Labor/Public Health & Safety Subcommittee hearing on National Institutes of Health reauthorization. "I urge the subcommittee to consider extending "the research budget to FDA, CDC, the Agency for Health Care Policy & Research, the Health Care Financing Administration and the Health Research & Services Administration," he said.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning